Drug Profile
BCX 9250
Alternative Names: BCX-9250Latest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator BioCryst Pharmaceuticals
- Class Small molecules
- Mechanism of Action ACVR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Fibrodysplasia ossificans progressiva